Catalent
CTLT
$55.92
Share price
0.22%
Change (1 day)
19.11%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Catalent (CTLT) - Cash on Hand
Cash on Hand as of December 2023 : $0.22 B
According to Catalent's latest financial reports the company has $0.22 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Catalent - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $0.28 B | -47.96% |
| 2022-06-30 | $0.53 B | -44.36% |
| 2021-06-30 | $0.96 B | 1.47% |
| 2020-06-30 | $0.95 B | 175.91% |
| 2019-06-30 | $0.34 B | -15.8% |
| 2018-06-30 | $0.41 B | 33.66% |
| 2017-06-30 | $0.30 B | 121.43% |
| 2016-06-30 | $0.13 B | -8.39% |
| 2015-06-30 | $0.15 B | 103.36% |
| 2014-06-30 | $74.4 M | -30.08% |
| 2013-06-30 | $0.10 B | -23.45% |
| 2012-06-30 | $0.13 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.25 B | 11.30% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $1.62 B | 610.18% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.17 B | -24.69% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.32 B | 40.92% | 🇺🇸 USA |